FindTrial
Sign In

Effectiveness of Bufei Formula and Bufei Yishen Formula as Adjuvant Treatment for Chronic Obstructive Pulmonary Disease

Effectiveness of Bufei Formula and Bufei Yishen Formula as Adjuvant Treatment for Chronic Obstructive Pulmonary Disease - Effectiveness of Bufei Formula and Bufei Yishen Formula as Adjuvant Treatment for Chronic Obstructive Pulmonary Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000056044
Enrollment
Unknown
Registered
2024-11-05
Start date
2024-11-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

None listed

Sponsors

Saga University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Studies were included if they met the following criteria: (1) Randomized controlled trials; (2) Patients treated with Bufei Formula or its modified versions; (3) Included relevant outcomes, such as exacerbation rates.

Exclusion criteria

Exclusion criteria: Studies were excluded if they: (1) Were not available in full text; (2) Were animal or cellular studies; (3) Involved patients without COPD; (4) Provided insufficient information or data.

Design outcomes

Primary

MeasureTime frame
The primary outcome was the annual exacerbation rate.—

Secondary

MeasureTime frame
Secondary outcomes included the Modified British Medical Research Council (mMRC) dyspnea scale, 6-minute walk distance (6MWD), and forced expiratory volume in one second as a percentage of the predicted value (FEV1%).—

Countries

Japan,North America,South America,Australia,Europe,Africa

Contacts

Public ContactYan Zhao

Saga University Hospital Liver Center

23624015@edu.cc.saga-u.ac.jp952-31-6511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026